Pet Drug Reports

Reported signs

Reported sign · VeDDRA term

Device breakage/fracture: reports listing this term

503reports listing the term, 2013–20260% of all reports
60reports, 12 months to March 202644 in the 12 months before
0%classed serious, as reportedall reports: 38.6%
27.2%of these reports concern dogscat 11.7%

503 reports in FDA's animal adverse event database list the term "Device breakage/fracture": 0% of all reports. It is a VeDDRA term, chosen by the person who coded the report to match what was described.

60 reports listed it in the 12 months to March 2026, up 36% from 44 in the 12 months before. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases.

By active ingredient, the drugs named most often in those reports are velagliflozin, meloxicam and pimobendan. That order mostly follows how many reports each has overall; the table gives the term's share within each drug's own reports as well.

27.2% of the reports concern dogs, 11.7% of the reports concern cats and 3.2% of the reports concern horses. Of reports listing this term that state seriousness, 0% were classed as serious; 2.6% record a death or euthanasia among the outcomes.

Drugs named most often in these reports, by active ingredient

Active ingredients recorded for the drugReports listing the termShare of that drug's own reports
Velagliflozin461%
Meloxicam220.1%
Pimobendan190.3%
Telmisartan111.6%
Ciclesonide62%
Eprinomectin30.1%
Hyaluronate Sodium20.2%
Omeprazole20.1%
Ivermectin10%
Ivermectin + Praziquantel10%

Ordered by number of reports, which mostly tracks how many reports a drug has overall. Across the whole database the term appears in 0% of reports. A drug's presence in a report means the animal received it, not that it produced the sign; FDA states that these data cannot be used to compare one product with another. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand.

Single ingredients, pooled across combinations

Active ingredientReports listing the termShare of the ingredient's own reports
Velagliflozin461%
Meloxicam220.1%
Pimobendan190.3%
Telmisartan111.6%
Ciclesonide62%
Eprinomectin30%
Hyaluronate Sodium20.2%
Ivermectin20%
Omeprazole20.1%
Praziquantel10%

Species split

Dog27.2%137
Cat11.7%59
Horse3.2%16
Cattle1.2%6
Pig0.6%3
Rabbit0.4%2

Coloured bar: share of reports listing this term. Grey bar: the species' share of all reports. The term appears in 0% of all dog reports; The term appears in 0% of all cat reports.

Trend

0714Apr 2021: 3May 2021: 5Jun 2021: 1Jul 2021: 2Aug 2021: 1Sep 2021: 2Oct 2021: 5Nov 2021: 4Dec 2021: 2Jan 2022: 32022Feb 2022: 2Mar 2022: 4Apr 2022: 5May 2022: 2Jun 2022: 0Jul 2022: 1Aug 2022: 0Sep 2022: 3Oct 2022: 0Nov 2022: 1Dec 2022: 0Jan 2023: 02023Feb 2023: 1Mar 2023: 2Apr 2023: 0May 2023: 1Jun 2023: 1Jul 2023: 0Aug 2023: 3Sep 2023: 1Oct 2023: 3Nov 2023: 1Dec 2023: 4Jan 2024: 22024Feb 2024: 2Mar 2024: 4Apr 2024: 0May 2024: 0Jun 2024: 4Jul 2024: 6Aug 2024: 3Sep 2024: 3Oct 2024: 2Nov 2024: 3Dec 2024: 1Jan 2025: 52025Feb 2025: 3Mar 2025: 14Apr 2025: 5May 2025: 7Jun 2025: 9Jul 2025: 5Aug 2025: 6Sep 2025: 3Oct 2025: 6Nov 2025: 7Dec 2025: 4Jan 2026: 52026Feb 2026: 3Mar 2026: 0

Reports by month FDA received them, five years to March 2026. The newest months are incomplete because FDA posts reports with a delay of three to six months.

037742013: 220132014: 1520142015: 6420152016: 5120162017: 5020172018: 5320182019: 4820192020: 3420202021: 3620212022: 2120222023: 1720232024: 3020242025: 7420252026: 82026

Outcomes and ages in these reports

Outcome recorded in the report

Recovered/Normal5.2%26
Recovered with Sequela2.4%12
Ongoing1.8%9
Died2.4%12
Euthanized0.2%1
Outcome Unknown54.3%273

Age of the animal

Under 1 year2.2%11
1 to 3 years2.4%12
4 to 7 years2.6%13
8 to 11 years0.8%4
12 years and over1.2%6
Age not given90.9%457
MeasureReports listing this termAll reports
Reports5031,357,245
Classed serious, of reports stating it0%38.6%
Death or euthanasia recorded, per 1,000 reports25.863.8

Grey bars and the right-hand column are the whole database. Outcomes are as stated by the reporter and describe the report as a whole, not this term alone.

Questions about "Device breakage/fracture"

What does "Device breakage/fracture" mean in an adverse event report?

It is a VeDDRA dictionary term picked to code what the reporter described. The report's free-text description is not published by FDA and is not shown here.

How many reports list device breakage/fracture?

503 reports through March 2026 (0% of all reports), 60 of them in the latest 12 months.

Which drugs are named most often alongside this term?

By active ingredient: velagliflozin (46), meloxicam (22), pimobendan (19), telmisartan (11) and ciclesonide (6). Drugs with many reports overall lead almost every term's list. Brands cannot be identified: openFDA masks them.

Which species are involved?

dog (27.2%), cat (11.7%), horse (3.2%) and cattle (1.2%).

Does a drug appearing here mean it produced this sign?

No such conclusion can be drawn. FDA states that "there is no certainty that the reported drug or device caused the adverse event" and that the event "may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources."

My animal shows this sign. What now?

This site cannot assess an animal. A veterinarian can; for an emergency, contact a veterinary emergency clinic. See the guide on when to call a vet.

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 1 Oct 2026. Spelling variants of the same VeDDRA term (for example with and without a cross-reference note) are pooled. No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.